So you are saying that there are exploration companies that know how to drill for wells that never experience a drop in production? SD has focused on horizontal wells that could experience faster drops in production that vertical wells.
it's also not hard to figure out what the PPS will do when there is any kind of positive news about oil futures or a really good quarterly report from SD
Good for you. There are not very many investors that can say they made a profit on DRL. It is a black hole that sucks in everything and rarely spits anything back out.
Nothing but pumpers on this board and they are not even pumping this stock.
Selling assets or not, they are a long way from being profitable so this scenario will continue to repeat itself until they start to make a profit.
It is not worth $20 unless they can start showing a profit. Selling assets to raise cash does not improve the chances for profitability.
income in seven states but I did not file except in my state of residence as the income in the other states is very minimal. 6.4% ordinary income; 1.26% interest income; AMT items 2.89%. I hope this answers your question.
I went through this with PVR that I held being aquired by RGP. The value of PVR post offer was quite a bit below the offer price for some time but eventually the PVR price rose as the deal got closer to the closing date. I kept the RGP after the merger and RGP has done nothing but go up since the merger. I am thinking I will keep the BBEP as well. If I were buying one of these right now I would look hard at the QRE.
With solid results like the last two wells produced there will be a day real soon when you will sell at 1.30 and never get a chance to buy it back for any less than you sold it for.
There is evidence that we may have a 10% market correction in the works. If the correction continues you can expect continued pressure on high beta stocks like this one.
There is a lot of risk of capital in biotech investing but the rewards can be incredible. In some cases the risk can be almost 100% if the company has no cash producing products and only one or two drugs in trials. I have owned Halo for quite some time and I expect this to be a big winner for me. My last big winner yielded an 180% return.
I live in Oklahoma not too far from Logan County. Yes, we have had unusual earthquake activity but most geologist have suggested that this is part of a normal cycle and not related to fracking. The strongest argument I have heard is that the earthquakes may be caused by saltwater disposal wells which OEDV is not operating. So stuff it Gary!
There are a lot of opportunities to short stocks and make a profit but there is way too much risk in being short this stock with the results for the last two wells that they drilled expected any day. If either one of the wells have solid results this stock is going to set a new 52 week high.
Not hardly. There were a couple of things that could cause a $7 share price but both of those things are past tense: FDA not allowing trials to continue and need to raise cash. You should cover now before there are any further positive updates on the trials.
Looking at the chart is usually helpful in cases like this. There is little resistance from $9 to $12 ($12 where the stock was trading prior to the clinical hold).
In your book value number are you including the write off on the NPL's? No potential investor will pay for loans that are not current .